Risofos 150 mg Tablet (Risedronate Sodium Tablets IP 150 mg) (Per Strip)

Risofos 150 mg Tablet contains Risedronate Sodium, a bisphosphonate medicine used to treat and prevent osteoporosis — a condition where bones become weak and brittle due to menopause, aging, or long-term steroid use.

It works by slowing down bone loss, increasing bone density, and reducing the risk of spine and hip fractures. Regular use of Risofos helps restore and maintain strong, healthy bones, especially in postmenopausal women and individuals at high risk of bone weakening.

Uses of Risofos 150 mg Tablet

• Treatment and prevention of osteoporosis in postmenopausal women

• Osteoporosis caused by corticosteroid use

• Paget’s disease of bone (abnormal bone growth and weakness)

• Improves bone density and reduces fracture risk

How Risofos 150 Works

Risedronate Sodium belongs to the bisphosphonate class of medicines. It works by binding to the bone surface and inhibiting osteoclasts, the cells responsible for bone resorption (breakdown).

By slowing down this process, it helps maintain the balance between bone formation and breakdown, allowing bones to stay stronger and denser over time.

Regular intake helps reduce the risk of fractures, particularly in the hip, spine, and wrist.

Dosage and Administration

• Route: Oral

• Typical Dose: One 150 mg tablet once a month or as directed by your physician

• Take the tablet with a full glass of plain water at least 30 minutes before breakfast or any other medication

• Do not lie down, eat, or drink anything else for 30 minutes after taking the tablet

• Swallow whole; do not chew or crush

Side Effects

Common Side Effects:

• Stomach pain or indigestion

• Constipation or diarrhea

• Muscle or joint pain

• Headache

Serious (Rare) Side Effects:

• Difficulty swallowing or chest pain

• Jaw pain or swelling (osteonecrosis of the jaw)

• Eye pain or inflammation

Seek medical attention if you experience severe or persistent side effects.

Precautions and Warnings

• Do not use if allergic to Risedronate Sodium or any bisphosphonates

• Avoid in patients with low blood calcium levels (hypocalcemia)

• Use with caution in kidney disease

• Not recommended for pregnant or breastfeeding women

• Ensure adequate calcium and vitamin D intake during treatment

• Store below 25°C, away from moisture and sunlight

Key Highlights

• Contains Risedronate Sodium 150 mg, a potent bisphosphonate

• Helps prevent bone loss and fractures caused by osteoporosis

• Taken once a month for convenient dosing

• Clinically proven to improve bone mineral density

• Manufactured by Cipla Ltd., ensuring reliable quality and efficacy